| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 52 |
| 1 | LISINOPRIL | 51 |
| 2 | PREDNISONE | 43 |
| 3 | ACETAMINOPHEN | 38 |
| 4 | ASPIRIN | 38 |
| 5 | ASPIRIN 325 MG | 38 |
| 6 | ASPIRIN 81 MG | 38 |
| 7 | LEVOTHYROXINE SODIUM | 38 |
| 8 | ALLOPURINOL | 37 |
| 9 | AMLODIPINE | 36 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LIDOCAINE, EPINEPHRINE | 1 | 0.1250 |
| 1 | ALUMINUM SULFATE TETRADECAHYDRATE, CALCIUM ACETATE MONOHYDRATE | 1 | 0.0156 |
| 2 | DIETHYLPROPION HYDROCHLORIDE | 1 | 0.0078 |
| 3 | BUPIVACAINE AND MELOXICAM | 1 | 0.0047 |
| 4 | BEVACIZUMAB-BVZR | 2 | 0.0028 |
| 5 | CALCIUM ANTACID | 1 | 0.0023 |
| 6 | DEXTROMETHORPHAN HBR, GUAIFENESIN, DOXYLAMINE SUCCINATE | 1 | 0.0023 |
| 7 | PSYLLIUM HUSK | 3 | 0.0022 |
| 8 | RIVASTIGMINE TARTRATE | 1 | 0.0022 |
| 9 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 9 | 0.0020 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 98 |
| 1 | Corticosteroid [EPC] | 89 |
| 2 | Benzodiazepine [EPC] | 58 |
| 3 | Platinum-based Drug [EPC] | 58 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 50 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 48 |
| 6 | Kinase Inhibitor [EPC] | 47 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 43 |
| 8 | Aromatase Inhibitor [EPC] | 41 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 40 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 3 | 0.0044 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 4 | 0.0019 |
| 2 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 1 | 0.0017 |
| 3 | Provitamin D2 Compound [EPC] | 33 | 0.0011 |
| 4 | Polyene Antifungal [EPC] | 28 | 0.0007 |
| 5 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 13 | 0.0006 |
| 6 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 1 | 0.0006 |
| 7 | Non-Standardized Fungal Allergenic Extract [EPC] | 1 | 0.0005 |
| 8 | Nitrogen Binding Agent [EPC] | 1 | 0.0004 |
| 9 | Aromatase Inhibitor [EPC] | 41 | 0.0004 |